Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pfister

Showing results (641-650 of 666) with videos related to

Pageof 67
Sort By:
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature Communications|December 10, 2015
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencingTyler S Alioto, Ivo Buchhalter, Sophia Derdak, et al.
Nature|March 1, 2018
The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Cancer Cell|January 16, 2026
Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastomaFlavia Bernardi, Jacob Torrejon, Irene Basili, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Cancer Research|July 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric CancersAniello Federico, Apurva Gopisetty, Didier Surdez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 67

Showing results (641-650 of 666) with videos related to

Sort By:
Pageof 67
Nature Genetics|April 11, 2017
Spatial heterogeneity in medulloblastomaA Sorana Morrissy, Florence M G Cavalli, Marc Remke, et al.
Nature Communications|December 10, 2015
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencingTyler S Alioto, Ivo Buchhalter, Sophia Derdak, et al.
Nature|March 1, 2018
The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|June 8, 2018
Author Correction: The landscape of genomic alterations across childhood cancersSusanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, et al.
Nature|July 22, 2014
Enhancer hijacking activates GFI1 family oncogenes in medulloblastomaPaul A Northcott, Catherine Lee, Thomas Zichner, et al.
Cancer Cell|January 16, 2026
Multiomic integration reveals tumoral heterogeneity of lipid dependence within lethal group 3 medulloblastomaFlavia Bernardi, Jacob Torrejon, Irene Basili, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Cancer Research|July 10, 2026
The ITCC-P4 PDX Platform Enables Preclinical Testing of Pediatric CancersAniello Federico, Apurva Gopisetty, Didier Surdez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Pageof 67